Taken together, we hypothesized that MnP would be effective in inhibiting obesity-induced NF-κB driven inflammation in the livers of obese mice, thus maintaining glucose homeostasis and promoting insulin sensitivity, while diminishing NAFLD. The gene discussed is NFKB1; the disease is obesity due to melanocortin 4 receptor deficiency.